v3.26.1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following summarizes option activity:
Number of
Options
Weighted-
Average
Exercise
Price
Remaining
Contractual
Term
(Years)
Aggregate
Intrinsic
Value ($, in thousands)
Balance—December 31, 20256,436,972 $9.17 7.75$127,945 
Granted1,623,121 26.17 
Exercised(336,941)7.21 
Forfeited
(238,285)13.25 
Expired— — 
Balance—June 30, 20267,484,867 $12.82 7.73$101,667 
Exercisable—June 30, 20263,472,101 $9.27 6.55$59,188 
Schedule of Restricted Stock Unit Activity
The following table summarizes information regarding the Company's RSUs:
Number of UnitsWeighted-Average
Grant Date Fair Value
Balance—December 31, 20256,007,515 $10.83 
Granted2,320,599 26.02 
Vested(1,832,747)10.53 
Forfeited(264,917)13.61 
Unvested Balance—June 30, 20266,230,450 $16.46 
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense included in the condensed consolidated statements of operations and comprehensive income (loss) was as follows (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Research and development
$3,406 $3,208 $6,558 $6,228 
Selling, general and administrative
9,356 7,281 16,894 14,039 
Total stock-based compensation expense
$12,762 $10,489 $23,452 $20,267